Literature DB >> 23076040

The Italian version of the Glaucoma Symptom Scale Questionnaire: translation, validation, and reliability.

Gemma Caterina Maria Rossi1, Gian Maria Pasinetti, Luigia Scudeller, Giovanni Milano, Andrea Mazzone, Marta Raimondi, Marco Bordin, Sara Lanteri, Paolo Emilio Bianchi.   

Abstract

PURPOSE: To validate the Italian version of the Glaucoma Symptom Scale (GSS) Questionnaire and its symptoms and function subscales.
METHODS: This transversal validation study enrolled nonhospitalized patients with glaucoma, and a reference sample of patients without eye diseases. Eligible participants had to be cognitively able to respond to a health status interview. The Italian self-administered versions of the 25-item National Eye Institute-Visual Function Questionnaire and the GSS Questionnaire were administered to all participants. Reliability and validity of the Italian translation of the GSS Questionnaire were tested using standard statistical methods for questionnaire validation.
RESULTS: Ninety-seven patients were enrolled. Cronbach α coefficient ranged from 0.72 to 0.92 across subscales and eyes. Test-retest stability was >85% for each subscale and eye. The control group of participants had better scale scores across all dimensions of vision-targeted health-related quality of life captured by the GSS Questionnaire (P<0.05) and there were good correlations between responses GSS Questionnaire subscales and analogous domains of the 25-item National Eye Institute-Visual Function Questionnaire.
CONCLUSIONS: The Italian version of the GSS Questionnaire has good validity, discriminatory power, internal consistence and reliability, showing psychometric properties comparable with those of the English version, and can therefore be used in clinical research as a specific measure of vision-related quality of life in Italian-speaking patients with ocular hypertension or glaucoma.

Entities:  

Mesh:

Year:  2013        PMID: 23076040     DOI: 10.1097/IJG.0b013e318225406c

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  Long-term safety and efficacy of autologous platelet lysate drops for treatment of ocular GvHD.

Authors:  S Pezzotta; C Del Fante; L Scudeller; G C Rossi; C Perotti; P E Bianchi; E Antoniazzi
Journal:  Bone Marrow Transplant       Date:  2016-09-05       Impact factor: 5.483

2.  A cross-sectional study on vision-related quality of life in patients with ocular GvHD.

Authors:  S Pezzotta; G C Rossi; L Scudeller; E Antoniazzi; P E Bianchi; C Perotti; C Del Fante
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

3.  Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent.

Authors:  Christian Pahljina; Stephanie Sarny; Lukas Hoeflechner; Thomas Falb; Gernot Schliessleder; Marlene Lindner; Domagoj Ivastinovic; Kaweh Mansouri; Ewald Lindner
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

4.  Psychometric properties of the Glaucoma Quality of Life-15 questionnaire: Use of explanatory factor analysis.

Authors:  Hamideh Mahdaviazad; Narges Roustaei; Masoumeh Beigom Masoumpour; Mohammad Reza Razeghinejad
Journal:  J Curr Ophthalmol       Date:  2018-01-17

5.  Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients.

Authors:  Ivano Riva; Lorenzo Legramandi; Eliana Rulli; Anastasios G Konstas; Andreas Katsanos; Francesco Oddone; Robert N Weinreb; Luciano Quaranta
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

6.  Glaucoma Symptom Scale: Psychometric properties of the Serbian version.

Authors:  Ivan Sencanic; Tatjana Gazibara; Jelena Dotlic; Miroslav Stamenkovic; Vesna Jaksic; Marija Bozic; Anita Grgurevic
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

7.  The 17-Item Computer Vision Symptom Scale Questionnaire (CVSS17): Translation, Validation and Reliability of the Italian Version.

Authors:  Gemma Caterina Maria Rossi; Federica Bettio; Mariano González-Pérez; Aba Briola; Gemma Ludovica Maria Pasinetti; Luigia Scudeller
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.